Lipoprotein(a): more interesting than ever after 50 years

Current Opinion in Lipidology
Joseph B DubéMarlys L Koschinsky

Abstract

Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular disease; we highlight the most recent research initiatives that have sought to define Lp(a)-dependent pathogenicity as well as pharmacologic approaches to lowering Lp(a). Recent large-scale meta-analyses have confirmed elevated Lp(a) concentrations to be a moderate but consistent prospective coronary heart disease (CHD) risk factor. The Mendelian randomization approach has also associated LPA variants with Lp(a) concentration and CHD risk. Discoveries linking Lp(a) to oxidized phospholipid burden have implicated a proinflammatory role for Lp(a) hinting at a new mechanism underlying the association with CHD risk, which adds to previous atherogenic and thrombogenic mechanisms. Most existing Lp(a)-lowering drug treatments almost always show simultaneous effects on other lipoproteins, making it difficult to assign any clinical outcome specifically to the effects of Lp(a) lowering. Early experiments with antisense oligonucleotides targeting apolipoprotein(a) mRNA seem to indicate the pleiotropic effects of Lp(a) reduction on LDL and HDL in mice. The mechanism linking Lp(a) concentration with concentrations of other blood lipids remains unknown but may provide an insight into...Continue Reading

References

Jul 1, 1992·The Journal of Clinical Investigation·E BoerwinkleH H Hobbs
Jan 23, 1999·The American Journal of Cardiology·D M CapuzziJ Brody
Mar 17, 2004·Current Opinion in Lipidology·Marlys L Koschinsky, Santica M Marcovina
Feb 15, 2007·JAMA : the Journal of the American Medical Association·Paul M RidkerNancy R Cook
Jul 14, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Sotirios TsimikasAlexandros D Tselepis
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
May 29, 2008·Nature Clinical Practice. Cardiovascular Medicine·Frederick F SamahaDaniel J Rader
Jul 3, 2008·Journal of Lipid Research·Claes BergmarkSotirios Tsimikas
Aug 7, 2008·The Journal of Clinical Endocrinology and Metabolism·Pia R KamstrupBørge G Nordestgaard
Feb 24, 2009·Nature Clinical Practice. Cardiovascular Medicine·Beate R JaegerUNKNOWN Group of Clinical Investigators
Mar 11, 2009·Biochimica Et Biophysica Acta·Constantinos C Tellis, Alexandros D Tselepis
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Mar 12, 2010·The New England Journal of Medicine·Paul W LadensonBo Angelin
May 8, 2010·Journal of the American College of Cardiology·Sebhat ErqouJohn Danesh
Jun 30, 2010·Journal of Lipid Research·Tanja X PedersenLars B Nielsen
Sep 11, 2010·Journal of the American College of Cardiology·Sotirios TsimikasS Matthijs Boekholdt
Nov 19, 2010·The New England Journal of Medicine·Christopher P CannonUNKNOWN Determining the Efficacy and Tolerability Investigators
Dec 4, 2010·Stroke; a Journal of Cerebral Circulation·James RonaldGail P Jarvik
Apr 9, 2011·Journal of the American College of Cardiology·Esther MerkiSotirios Tsimikas
Oct 20, 2011·Circulation. Cardiovascular Genetics·Yonghong LiJames J Devlin
Nov 17, 2011·The New England Journal of Medicine·William E BodenWilliam Weintraub

❮ Previous
Next ❯

Citations

Jul 17, 2013·Journal of Cardiovascular Translational Research·Richard G LeeRosanne M Crooke
Jun 6, 2013·European Heart Journal·Karam M KostnerGerhard M Kostner
Jul 6, 2013·Journal of Lipid Research·Gregor LeibundgutSotirios Tsimikas
Nov 9, 2012·Clinical Lipidology·Qibin Qi, Lu Qi
Jun 24, 2014·Analytical and Bioanalytical Chemistry·Berta Esteban-Fernández de ÁvilaJosé M Pingarrón
May 9, 2015·Critical Reviews in Clinical Laboratory Sciences·Mariëtte R BoonPatrick C N Rensen
Mar 14, 2013·BioMed Research International·Michele MalaguarneraAlessandro Frigiola
Jul 18, 2015·Atherosclerosis·Kazuhiko KotaniUNKNOWN Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
May 21, 2016·Nature Reviews. Endocrinology·Katrina L EllisGerald F Watts
Dec 9, 2016·Expert Opinion on Emerging Drugs·Marie-Jeanne Bertrand, Jean-Claude Tardif
Feb 6, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Catarina OliveiraFrancois Helle
Apr 9, 2016·Journal of Clinical Lipidology·Jae-Seung YunSeung-Hyun Ko
Oct 18, 2015·Journal of Lipid Research·Corey A ScipioneMarlys L Koschinsky
Mar 25, 2017·Progress in Retinal and Eye Research·Sayantan DattaJames T Handa
Feb 4, 2016·Journal of Lipid Research·Joseph L Witztum, Henry N Ginsberg
Nov 6, 2015·Journal of Lipid Research·Mark J GrahamSotirios Tsimikas
Dec 10, 2015·Journal of Lipid Research·Michael B Boffa, Marlys L Koschinsky
May 15, 2013·Journal of Lipid Research·Philipp WiesnerYury I Miller
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Mar 20, 2018·Current Opinion in Lipidology·Laurent Yvan-Charvet, Bertrand Cariou
Feb 20, 2018·BioMed Research International·Zi-Kai SongLing Qin
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Mar 15, 2014·Circulation Research·Nabil G SeidahMajambu Mbikay
Aug 26, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Archna BajajUNKNOWN Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*
Jun 14, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Theodosios KyriakouUNKNOWN PROCARDIS Consortium
Dec 12, 2013·Obstetrics & Gynecology Science·Jin Ju Kim, Young Min Choi
Sep 21, 2018·Current Opinion in Lipidology·Lubna AliJeffrey Kroon
Oct 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Jacqueline S DronRobert A Hegele
Jan 15, 2019·Journal of Cellular Physiology·Amir Abbas Momtazi-BorojeniAmirhossein Sahebkar
Feb 1, 2019·Circulation Research·Robert S RosensonWolfgang Koenig
Feb 1, 2019·Circulation Research·Robert A Hegele, Sotirios Tsimikas
Apr 30, 2019·Scandinavian Cardiovascular Journal : SCJ·Setor K KunutsorJari A Laukkanen
May 18, 2016·Nature Reviews. Disease Primers·Brian R LindmanPhilippe Pibarot
May 15, 2013·Current Cardiology Reports·Peter O Kwiterovich
Jul 25, 2013·Current Cardiology Reports·Tanya E Keenan, Daniel J Rader
Aug 31, 2013·Current Atherosclerosis Reports·Michael B Boffa, Marlys L Koschinsky
Jun 14, 2014·Journal of Immigrant and Minority Health·Tam Truong DonnellySarah Omar
Mar 31, 2016·Clinical Diabetes and Endocrinology·Ramesh Saeedi, Jiri Frohlich
Oct 7, 2019·Prague Medical Report·Danica LabudovicSonja Topuzovska
Oct 9, 2012·Current Opinion in Lipidology·Brian Kolski, Sotirios Tsimikas

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.